Australia's largest stock trading and investment forum Australia's #1 stock forum

RAC

Click for more information

3.77%

$1.53 race oncology ltd

General Comments / Chat, page-10311

First 10311 Last

Share
Profile

Follow
LongTony

2,780 Posts.

2468

25/01/24

17:34

Post #: 72070399
Share

Originally posted by Kron00: ↑

Patch my head hurts after reading your posts lol

RC220 Circa 6 months
P1 12-18 months - FDA has 30 days to review an IND, Maybe they make submission at the same time Aus kicks off in H2 - Mostly Aus sites to keep costs down but throw in a US site or 2 in prep for opening a P2 there as well. Remember trial is Bayesian design so allows some flexibility and advantages with the accumulation and reporting of data (recommend going and reading up on this)
P2 likely starts H1 2026 - 18 - 24 months we are in 2028
To hit your timelines, Approval would need to be granted off Interim data. Not sure how many cases of it happening off P1 data, but there is precedent off early P2.

FDA = "In situations where standard-of-care exists, a distinction between small, incremental improvements, and game-changing effects must be made in order for Breakthrough Therapy designation to be granted"

Id assume the end points RAC have come up with are not just wild guesses and fairly well researched, to be enough to be granted use if it demonstrates any sort of efficacy as cardioprotective. Of course all of these timelines matter for approval and not a transaction.

Expand

This post just made me think: one or two US sites, friendly sites, like MD Anderson ...

RAC Price at posting: 74.5¢ Sentiment: Buy Disclosure: Held
13 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Update: Index pulls back from record highs | October 16, 2024

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

BM8

Battery Age Minerals gets set to capitalise on critical mineral demand

PME

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

JBY

James Bay latest lithium player to pivot to other metals amidst lithium slump

There are more pages in this discussion • 1,587 more messages in this thread...

First 10311 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.53		Change -0.060(3.77%)		Mkt cap ! $260.7M

Open	High	Low	Value	Volume
$1.59	$1.59	$1.53	$83.43K	53.65K

Buyers (Bids)

No.	Vol.	Price($)
1	20575	$1.53

Sellers (Offers)

Price($)	Vol.	No.
$1.57	300	1

View Market Depth

No.	Vol.	Price($)
1	20575	1.530
1	500	1.525
1	2750	1.510
4	14647	1.505
7	18242	1.500

Price($)	Vol.	No.
1.570	300	1
1.590	10776	3
1.600	23400	1
1.650	17029	2
1.690	6570	3

Last trade - 16.10pm 16/10/2024 (20 minute delay)

RAC (ASX) Chart

SPONSORED BY